Announcements Trials
Browse Landscape

Phase

Phase 2/3 2Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Mouth Neoplasms 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2Carcinoma 2Oropharyngeal Neoplasms 1

Interventions

Cisplatin 8Radiotherapy 6Radiotherapy, Intensity-Modulated 3Magnetic Resonance Spectroscopy 3Carboplatin 3Taxes 2Specimen Handling 2Platinum 2Paclitaxel 2Observation 2Fluorouracil 2Cetuximab 21,2-diaminocyclohexaneplatinum II citrate 2sargramostim 1pembrolizumab 1durvalumab 1dehydroftorafur 1Watchful Waiting 1Tretinoin 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sucralfate 1Standard of Care 1Salts 1Radiation 1Nivolumab 1Gabapentin 1Fluorodeoxyglucose F18 1Drug Therapy 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Oropharyngeal Neoplasms × (225)Ac-DOTA-c(RGDyK) × Clear all
NCT07441681 2026-05-04

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

NRG Oncology

Phase 3 Not yet recruiting
454 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡